한글목차

수의용 백신 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 125억 4,000만 달러에서 2026년에는 132억 8,000만 달러로, CAGR 5.9%로 확대할 전망입니다. 지난 수년간의 성장 요인으로는 동물 질병의 확산 증가, 가축 사육두수 증가, 반려동물 증가, 백신 접종을 지원하는 정부 규제, 백신 연구 및 생산 기술 발전 등을 들 수 있습니다.

수의용 백신 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 167억 9,000만 달러에 달하며, CAGR은 6.0%에 달할 전망입니다. 예측 기간 중의 성장은 신흥 바이오의약품 백신 기술, 예방 수의학에 대한 수요 증가, DNA 백신 및 재조합 백신의 채택, 신흥 시장에서의 백신 접종 프로그램 확대, 인수공통전염병 예방에 대한 인식 개선에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 신규 가축 백신 개발, 반려동물 백신 접종 프로그램 확대, 재조합 백신 및 톡소이드 백신 보급, 다질병 혼합백신 채택, 인수공통전염병 전파 예방에 대한 관심 등이 있습니다.

다양한 질병에 드는 동물의 수가 증가함에 따라 향후 수년간 수의학 백신 시장의 성장을 촉진할 것으로 예측됩니다. 다발성 질환을 앓고 있는 동물이란 비인간 동물이 동시에 또는 연속적으로 병태를 경험하고 그 결과 복합적인 신체적, 심리적, 기능적 손상을 입어 복지에 심각한 영향을 미치는 상태를 말합니다. 이 증가는 주로 동물 서식지의 위생 상태 악화에 기인합니다. 수의학 백신은 면역 체계를 자극하여 감염을 예방하고, 질병의 심각성을 줄이고, 전염을 억제하고, 전반적인 건강과 복지를 개선함으로써 이러한 동물을 돕습니다. 예를 들어 영국 정부 기관인 영국 보건안전청(UK Health Security Agency)에 따르면 2025년 7월 기준 2024년 확인된 렙토스피라증(세균성 인수공통전염병) 확진 및 의심 사례는 154건으로 2023년 138건에서 11.6% 증가한 것으로 나타났습니다. 따라서 여러 질병에 드는 동물 증가가 수의용 백신 시장을 주도하고 있습니다.

동물용 백신 시장의 주요 기업은 경쟁 우위를 유지하기 위해 신제품을 개발하고 있습니다. 이들 신제품에는 개선된 제형, 보다 광범위한 병원체 커버리지, 향상된 안전성 및 효능 프로파일을 갖춘 첨단 질병 특이적 백신이 포함됩니다. 예를 들어 2023년 6월 미국 제약사 머크 동물 건강(Merck Animal Health)는 3종 혼합 돼지 백신 '서캄벤트 CML'을 출시했습니다. 본 백신은 돼지 써코바이러스 2a형(PCV-2a), 돼지 써코바이러스 2d형(PCV-2d), 마이코플라즈마 하이오뉴모니아, 로소니아 인트라셀룰라리스에 대한 방어 효과가 있습니다. 여러 항원과 보조제 시스템을 하나의 바이알에 결합하여 필요한 용량을 줄이고 생후 3주령 이상의 돼지에 1회 근육주사로 접종할 수 있습니다. 이를 통해 백신 접종을 간소화하여 동물과 사육자 모두의 부담을 줄일 수 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

A veterinary vaccine is a biological preparation designed to stimulate the immune response of an animal, aiming to reduce animal suffering, prevent the transmission of microorganisms within the animal population, and enhance the immune strength of animals for improved health. Additionally, veterinary vaccines play a crucial role in preventing the transmission of diseases from animals to humans.

Various types of veterinary vaccines include live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other vaccine variants. Inactivated vaccines, distinct from live attenuated vaccines, consist of dead or inactivated viruses and bacteria. The diseases targeted by these vaccines encompass anaplasmosis, canine parvovirus, foot and mouth disease, Newcastle disease, distemper disease, influenza, and porcine reproductive and respiratory syndrome. The application areas for veterinary vaccines extend to both livestock vaccines and companion animal vaccines.

Tariffs have impacted the veterinary vaccines market by increasing costs for imported vaccines, biological raw materials, and cold-chain equipment, particularly affecting asia-pacific and european regions with high reliance on imports. This has influenced procurement and pricing for livestock and companion animal vaccines. On the positive side, tariffs have encouraged local vaccine production and innovation, leading to development of cost-effective alternatives and strengthening regional supply chains for long-term market resilience.

The veterinary vaccines market research report is one of a series of new reports from The Business Research Company that provides veterinary vaccines market statistics, including veterinary vaccines industry global market size, regional shares, competitors with a veterinary vaccines market share, detailed veterinary vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary vaccines industry. This veterinary vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary vaccines market size has grown strongly in recent years. It will grow from $12.54 billion in 2025 to $13.28 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increasing prevalence of animal diseases, rising livestock population, growth in companion animals, government regulations supporting vaccination, advancements in vaccine research and production.

The veterinary vaccines market size is expected to see strong growth in the next few years. It will grow to $16.79 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to emerging biopharmaceutical vaccine technologies, rising demand for preventive veterinary care, adoption of dna and recombinant vaccines, expansion of vaccination programs in emerging markets, increasing awareness of zoonotic disease prevention. Major trends in the forecast period include development of novel livestock vaccines, growth in companion animal vaccination programs, expansion of recombinant and toxoid vaccines, adoption of multi-disease combination vaccines, focus on preventing zoonotic disease transmission.

The rising number of animals affected by various diseases is expected to drive the growth of the veterinary vaccine market in the coming years. Animals suffering from multiple diseases refers to non-human animals experiencing concurrent or sequential pathological conditions, resulting in compounded physical, psychological, and functional harm that severely affects their welfare. This increase is largely due to poor sanitation and hygiene in animal habitats. Veterinary vaccines support these animals by stimulating their immune systems to prevent infections, reduce disease severity, limit transmission, and improve overall health and welfare. For example, in July 2025, according to the UK Health Security Agency, a UK-based government organization, 154 confirmed and probable leptospirosis cases (a bacterial zoonotic infection) were reported in 2024, marking an 11.6% increase from 138 cases in 2023. Therefore, the growing number of animals affected by multiple diseases is propelling the veterinary vaccine market.

Key players in the veterinary vaccine market are developing new products to maintain a competitive edge. These new products include advanced, disease-specific vaccines with improved formulations, broader pathogen coverage, and enhanced safety and efficacy profiles. For instance, in June 2023, Merck Animal Health, a US-based pharmaceutical company, launched Circumvent CML, a three-in-one swine vaccine. This vaccine protects against Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsonia intracellularis. By combining multiple antigens and adjuvant systems in a single bottle, it reduces the required dosage and is administered as a single intramuscular injection to pigs aged three weeks or older, simplifying vaccination and reducing stress for both animals and caretakers.

In April 2024, Virbac SA, a France-based provider of animal health products and services, including pharmaceuticals, vaccines, and preventive care solutions for companion and farm animals, acquired Sasaeah Pharmaceutical Co. Ltd. for an undisclosed amount. Through this acquisition, Virbac aimed to strengthen its presence in the Asia Pacific animal health market and enhance its vaccine and pharmaceutical portfolio, particularly in farm animal segments, by integrating Sasaeah's established manufacturing, R&D capabilities, and strong regional distribution network. Sasaeah Pharmaceutical Co. Ltd., based in Japan, develops, manufactures, and markets a broad range of veterinary pharmaceutical products and vaccines for major species, including cattle and other farm animals, supported by facilities in Japan and Vietnam.

Major companies operating in the veterinary vaccines market are Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Sante Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, DBK Pharma S.A.E.

North America was the largest region in the veterinary vaccines market in 2025. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary vaccines market consists of sales of messenger RNA vaccine, viral vector vaccine, and subunit vaccine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Vaccines Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Vaccine Type: Live Attenuated; Inactivated (Killed); Recombinant Or Subunit; mRNA And DNA; Other Vaccine Types
• 2) By Animal Type: Canine; Feline; Equine; Bovine; Swine; Poultry; Other Animal Types
• 3) By Disease Type: Viral Diseases; Bacterial Diseases; Parasitic Diseases; Other Disease Types
• 4) By Route Of Administration: Injectable; Oral; Intranasal; Other Route Of Administrations
• 5) By End-User Or Customer Type: Pet Owners Or Companion Animal Owners; Farm Or Livestock Owners; Veterinary Clinics Or Hospitals; Animal Shelters Or Rescue Organizations; Research Or Educational Institutions
• Subsegments:
• 1) By Live Attenuated: Viral Vaccines; Bacterial Vaccines; Parasitic Vaccines
• 2) By Inactivated (Killed): Viral Vaccines; Bacterial Vaccines; Parasitic Vaccines
• 3) By Recombinant Or Subunit: Viral Vaccines; Bacterial Vaccines
• 4) By mRNA And DNA: Viral Vaccines; Bacterial Vaccines
• 5) By Other Vaccine Types: Toxoid Vaccines; Conjugate Vaccines; Vector-based Vaccines
• Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim GmbH; Merck & Co. Inc.; Elanco Animal Health Incorporated; Ceva Sante Animale.; Virbac Group; HIPRA; Biogenesis Bago; Kyoritsu Seiyaku Corporation; Phibro Animal Health Corporation; Century Vaccines Limited; Bayer Animal Health; Cadila Vaccines Ltd.; Cargill India Pvt. Ltd.; China Animal Healthcare Ltd.; Jurox Pty Ltd; Nimrod Veterinary Products Ltd.; Bimeda; Animalcare; MSD Animal Health; Interfeed; Biotex Plus Ltd.; Belfarmacom; IDT Biologika; UCBVET; Lemavet; Syntec; Sauvet; Vetanco; Chemo Argentina; Brouwer; Agrovet Market Animal Health; DBK Pharma S.A.E.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Veterinary Vaccines Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Veterinary Vaccines Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Veterinary Vaccines Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Veterinary Vaccines Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Development Of Novel Livestock Vaccines
  • 4.2.2 Growth In Companion Animal Vaccination Programs
  • 4.2.3 Expansion Of Recombinant And Toxoid Vaccines
  • 4.2.4 Adoption Of Multi-Disease Combination Vaccines
  • 4.2.5 Focus On Preventing Zoonotic Disease Transmission

5. Veterinary Vaccines Market Analysis Of End Use Industries

• 5.1 Livestock Farmers
• 5.2 Companion Animal Owners
• 5.3 Veterinary Clinics
• 5.4 Animal Health Research Institutes
• 5.5 Zoos & Wildlife Parks

6. Veterinary Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Veterinary Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Veterinary Vaccines Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Veterinary Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Veterinary Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary Vaccines Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary Vaccines Market Segmentation

• 9.1. Global Veterinary Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Live Attenuated, Inactivated (Killed), Recombinant Or Subunit, mRNA And DNA, Other Vaccine Types
• 9.2. Global Veterinary Vaccines Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Canine, Feline, Equine, Bovine, Swine, Poultry, Other Animal Types
• 9.3. Global Veterinary Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Viral Diseases, Bacterial Diseases, Parasitic Diseases, Other Disease Types
• 9.4. Global Veterinary Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Injectable, Oral, Intranasal, Other Route Of Administrations
• 9.5. Global Veterinary Vaccines Market, Segmentation By End-User Or Customer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pet Owners Or Companion Animal Owners, Farm Or Livestock Owners, Veterinary Clinics Or Hospitals, Animal Shelters Or Rescue Organizations, Research Or Educational Institutions
• 9.6. Global Veterinary Vaccines Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines
• 9.7. Global Veterinary Vaccines Market, Sub-Segmentation Of Inactivated (Killed), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines
• 9.8. Global Veterinary Vaccines Market, Sub-Segmentation Of Recombinant Or Subunit, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Viral Vaccines, Bacterial Vaccines
• 9.9. Global Veterinary Vaccines Market, Sub-Segmentation Of mRNA And DNA, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Viral Vaccines, Bacterial Vaccines
• 9.10. Global Veterinary Vaccines Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Toxoid Vaccines, Conjugate Vaccines, Vector-based Vaccines

10. Veterinary Vaccines Market Regional And Country Analysis

• 10.1. Global Veterinary Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Veterinary Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary Vaccines Market

• 11.1. Asia-Pacific Veterinary Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary Vaccines Market

• 12.1. China Veterinary Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary Vaccines Market

• 13.1. India Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary Vaccines Market

• 14.1. Japan Veterinary Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary Vaccines Market

• 15.1. Australia Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary Vaccines Market

• 16.1. Indonesia Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary Vaccines Market

• 17.1. South Korea Veterinary Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary Vaccines Market

• 18.1. Taiwan Veterinary Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary Vaccines Market

• 19.1. South East Asia Veterinary Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary Vaccines Market

• 20.1. Western Europe Veterinary Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary Vaccines Market

• 21.1. UK Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary Vaccines Market

• 22.1. Germany Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary Vaccines Market

• 23.1. France Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary Vaccines Market

• 24.1. Italy Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary Vaccines Market

• 25.1. Spain Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary Vaccines Market

• 26.1. Eastern Europe Veterinary Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary Vaccines Market

• 27.1. Russia Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary Vaccines Market

• 28.1. North America Veterinary Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary Vaccines Market

• 29.1. USA Veterinary Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary Vaccines Market

• 30.1. Canada Veterinary Vaccines Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary Vaccines Market

• 31.1. South America Veterinary Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary Vaccines Market

• 32.1. Brazil Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary Vaccines Market

• 33.1. Middle East Veterinary Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary Vaccines Market

• 34.1. Africa Veterinary Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Veterinary Vaccines Market, Segmentation By Vaccine Type, Segmentation By Animal Type, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary Vaccines Market Regulatory and Investment Landscape

36. Veterinary Vaccines Market Competitive Landscape And Company Profiles

• 36.1. Veterinary Vaccines Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Veterinary Vaccines Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Veterinary Vaccines Market Company Profiles
  • 36.3.1. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary Vaccines Market Other Major And Innovative Companies

• Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd., Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health

38. Global Veterinary Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Vaccines Market

40. Veterinary Vaccines Market High Potential Countries, Segments and Strategies

• 40.1 Veterinary Vaccines Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Veterinary Vaccines Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Veterinary Vaccines Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer